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Purpose: The antibiotic effect of rice-fluid on Helicobacter pylori infection was investigated using a Mongolian 
gerbil model. 
Methods: Gerbils were divided into four groups: H. pylori -infected, rice-fluid-treated animals (group A); H. py-
lori -infected, untreated animals (group B); uninfected, rice-fluid-treated animals (group C); and uninfected, un-
treated animals (group D). Group A and B animals were killed 14 weeks after H. pylori infection and group C 
and D animals were killed at the same age. The stomachs were examined for histology, 
5'-bromo-2'-deoxyuridine (BrdU) labeling, and the bacterial burden. Serum anti-H. pylori antibody titers were 
also tested.   
Results: The positive incidence of H. pylori -culture was 25 and 84 % in groups A and B, respectively (p<0.01). 
Both the degree of inflammation and the BrdU labeling index in group A were significantly lower than those in 
group B. 
Conclusions: Rice-fluid showed an antibiotic effect on H. pylori and an anti-inflammatory effect on the H. pylori 
-associated gastritis. 
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1.  Introduction 
Helicobacter pylori is the most important etiologi-
cal agent of chronic gastritis and peptic ulcer and it is 
also known to increase the risk of gastric cancer [1-4]. 
The Mongolian gerbil is a useful animal model to in-
vestigate human gastric disorders: H. pylori easily in-
fects the stomach of Mongolian gerbils, thereby in-
ducing human-mimicking gastritis, peptic ulcer and 
intestinal metaplasia in the stomach. In addition, this 
animal model can develop gastric adenocarcinoma by 
inoculation of H. pylori [5]. 
Accumulating evidence has demonstrated that 
the eradication of H. pylori in the stomachs by the ad-
ministration of oral antimicrobial agents results in the 
resolution of H. pylori-associated gastroduodenal dis-
eases [6-8]. In addition, the eradication of H. pylori is 
also reported to decrease the risk of gastric carcino-
genesis in Mongolian gerbils [9, 10]. Triple combina-
tion therapy, using two antibacterial antibiotics and a 
proton pump inhibitor, achieved a high eradication 
rate [11-13]. However, such combination therapy does 
not always successfully eradicate H. pylori. In recent 
years, the increased occurrence of clarithromycin- 
and/or metronidazole-resistant strains of H. pylori has 
become a problem [14, 15]. In addition, antibiotics 
cannot be used due to drug allergies in some patients 
and the antibiotic therapy is also occasionally associ-
ated with adverse events. Furthermore, it is consid-
ered to be inappropriate to administer antimicrobial 
agents long-term to prevent H. pylori infection. Con-
sequently, it is important to investigate the use of 
non-antibiotic therapies for H. pylori infection, which 
are highly effective and safe. 
Many investigators have researched 
non-antibiotic therapies for H. pylori infection [16-21], 
utilizing plant extracts and constituents, probiotics, 
antioxidants, and so on. However, regarding 
rice-extract, no studies have yet been reported except 
ours [22]. In our previous study using an animal 
model, a Rice Power Extract (RPE) showed a suppres-
sive effect on gastric mucosal inflammation, but it did 
not show any significant decrease in the viable H. py-
lori obtained from stomach samples [22]. This time, we 
employed a different type of rice extract, Japa-
nese-Rice-Fluid (JRF, patent number 3655880). The JRF 
has already been reported to show a strong in vitro 
bactericidal activity against H. pylori [23] and there 
were no resistant strains of H. pylori [23]. In addition, it Int. J. Med. Sci. 2007, 4 
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is easily manufactured and has recently been adopted 
as an ingredient in several kinds of liquid food as the 
main supplemental ingredient, and it is commercially 
available all over Japan.   
In this study, we investigated the antibiotic effect 
of JRF on H. pylori infection in vivo and its 
anti-inflammatory effects on the H. pylori-induced 
gastritis, using a Mongolian gerbil model. 
2.  Materials and Methods 
Animals 
Specific pathogen-free male Mongolian gerbils 
(Meriones unguiculatus) (MGS/Sea) (Seac Yoshitomi, 
Ltd., Fukuoka, JAPAN), 7 weeks old, were housed in 
plastic cages with hard wood chips in an 
air-conditioned biohazard room for infection with a 12 
hours light-12 hours dark cycle. They were given food 
(CE-2, Clea Japan Inc., Tokyo, Japan) and water or the 
JRF as drinking water in bottles ad libitum. Approval 
for this study was obtained prior to experimentation 
from the animal ethics committee, and all procedures 
were performed in compliance with Guidelines for the 
Care and Use of Laboratory Animals in Shinshu Uni-
versity. 
Bacterial inoculation 
H. pylori (ATCC43504, CagA+, VacA+, American 
Type Culture Collection, Rockville, MD, USA) was 
grown in Brucella broth (Becton Dickinson, Cockeys-
ville, MD, USA) containing 10 % v/v horse serum at 
37 °C under microaerophilic conditions (15% CO2) at 
high humidity for 40 hours with gentle shaking (150 
rpm). After each gerbil had fasted for 24 hours, sam-
ples containing 1x 109    colony-forming units (CFU) 
per milliliter (0.8 ml) were used as the inoculum, 
which were delivered via an oral catheter.   
Chemicals 
The production of the Japanese rice-fluid (JRF) 
was conducted in 5 phases (patent number 3655880). 
Phase 1 involved the addition of 15-times volume of 
distilled water to polished Japanese raw rice. Phase 2 
involved their incubation at 128 °C under pressure of 
0.1 to 0.5 Mpa for 5 min. In phase 3, they were com-
pleted mixed by homogenizing, and then were cooled 
down to 40 to 55 °C. In phase 4, they were treated for 
15 to 30 min. with the addition of some proteinase and 
amylase complexes, including alpha-amylase, 
beta-amylase, and gluco-amylase. In the last phase 5, 
the added enzymes were inactivated by heating the 
mixture up to 95 °C. Based on our preliminary ex-
periment, the JRF containing 25% saccharides was 
used in this study. The JRF also contains 1 % protein, 
but no lipid.   
Experimental protocol  
Fifty gerbils were divided into 4 groups. Group 
A comprised 20 gerbils that were inoculated with H. 
pylori at 7 weeks of age and given JRF as drinking wa-
ter in bottle ad libitum from 2 weeks until 14 weeks 
after H. pylori inoculation. Group B comprised 19 ger-
bils that were inoculated with H. pylori and given 
autoclaved distilled water. Group C (6 gerbils) and D 
(5 gerbils) were not inoculated with H. pylori; Group C 
was given JRF and Group D was given distilled water. 
Following a 24-h fasting period, with free access to 
drinking water without JRF, the gerbils were sacri-
ficed. All gerbils were sacrificed under deep ether an-
esthesia at 21 weeks of age and then their stomachs 
were excised. Thirty minutes before being sacrificed, 
the gerbils were given 5'-bromo-2'deoxyuridine 
(BrdU) intraperitoneally at a dose of 200 mg/Kg. The 
excised stomachs were cut open along the greater 
curvature and then were divided in half along the 
lesser curvature. One half was used for a culture study 
while the other was used for histopathological analy-
ses. (Fig. 1) 
 
Figure 1: Experimental protocol. HP: Inoculation of Helico-
bacter pylori. w: weeks. The rice-fluid (RF) was given ad libi-
tum from 9 weeks of age to the end of the experiment. All ger-
bils were sacrificed 14 weeks after inoculation of HP (21 weeks 
of age).  
Bacterial cultures 
The excised stomachs (half) were homogenized 
with 5 ml of Brucella broth and then the resulting 
samples were diluted serially, from 1:10 to 1:1000000, 
with Brucella broth for the culture of H. pylori. Ali-
quots (100 ul) of the dilutions were inoculated on to H. 
pylori agar plates (Nissui Pharmaceutical Co, Tokyo, 
Japan). All plates were incubated at 35 °C for 7 days 
under microaerophilic conditions and high humidity. 
The density of H. pylori was assessed as CFU per 
whole stomach. 
Serology 
Anti-H. pylori IgG values in sera from gerbils 
were determined by ELISA developed in our labora-
tory [4,24]. The reference serum, which was pooled 
from sera of anti-H. pylori IgG-positive gerbils, was 
diluted serially from 1:100 to 1:3,200 with PBS (pH 7.4) 
containing 4% bovine serum albumin, and the amount 
of anti-H. pylori IgG corresponding to a 1:3,200 dilution 
was expressed as a reference value of a 1.0 arbitrary 
index (AI). Microwell strips coated with H. pylori an-
tigens from a GAP-IgG kit (Biomerica, Newport Beach, 
Calif.) were used. The antigens in the GAP-IgG kit Int. J. Med. Sci. 2007, 4 
 
205
were acid extracts of organisms  derived from the 
H. pylori ATCC 43504 strain. Aliquots of 100 µl of ref-
erence serum or 1:200 of diluted serum were added to 
the wells, and the plates were incubated for 1  h at 
room temperature. After washing was done, 100 µl of 
HRP-conjugated anti-gerbil IgG (diluted 1:1,500 in PBS 
containing 0.05% Tween 20 [PBS-T]) was added, and 
the plates were incubated for 30  min at room tem-
perature. The plates were washed and incubated with 
100  µl of substrate  (0.35 mg  of 
3,3',5,5'-tetramethylbenzidine per ml and 0.15  mg  of 
H2O2 per ml) for 10 min. After stopping the reaction 
with 1 N HCl, the color was read at 450 nm. The serum 
anti-H. pylori IgG value was determined from a stan-
dard curve of calibrators.  
Histopathological analyses 
The excised stomachs (half) were fixed in 20 % 
phosphate-buffered formalin for 24 hours at 4℃ and 
then were cut along the longitudinal axis into five 
strips, which were then embedded in paraffin. Tissue 
sections were stained with hematoxylin and eosin 
(HE) for morphological observations, and with alcian 
blue (pH 2.5)-periodic acid Schiff (PAS) for the detec-
tion of mucin-containing cells. Because the inflamma-
tory component of the mucosa was virtually identical 
to that found in human H. pylori gastritis, the degree of 
inflammation could be graded according to the Up-
dated Sydney System (visual analogue scale: normal, 
0; mild,1; moderate, 2; marked, 3) [25]. The mucosal 
thickness was measured at ten different arbitrarily 
selected points in the mid-antrum and mid-body. In 
addition, tissue sections were immunostained for H. 
pylori (rabbit polyclonal anti- H. pylori antibody, 1:20; 
DAKO, Kyoto, Japan), using an indirect immunoper-
oxidase method (peroxidase-labeled goat anti-mouse 
Ig antibody, 1:50, DAKO; peroxidase-labeled goat 
anti-rabbit Ig antibody, 1:50, DAKO).   
The BrdU labeling was visualized using mouse 
monoclonal anti-BrdU antibody (1:50, DAKO), as de-
scribed previously [4]. The labeling index was calcu-
lated by expressing the number of BrdU-positive 
epithelial cells as a percentage of the total number of 
epithelial cells from 10 different points, which were 
arbitrary selected, in the lesser curvature of the 
mid-antrum. 
Statistical analyses 
The statistical significance of the incidence of 
positive bacterial culture was evaluated using Fisher's 
exact test; the other factors were assessed by Student's 
t test after an analysis of variance. P values of less than 
0.05 were considered to indicate significant differ-
ences. The results are expressed as the mean±standard 
deviation. 
3.  Results 
Bacteriological and serological findings 
In group A (H. pylori inoculation followed by JRF 
treatment), bacterial culture was positive in 5 of 20 
gerbils (25 %) and then the density of H. pylori coloni-
zation was (3.8±2.3) X 102 CFU/stomach. Both of the 
incidence and density were significantly less than that 
in group B (H. pylori inoculation without JRF treat-
ment. 84 % and (8.6±9.9) x 104  CFU/stomach, re-
spectively). The titers of anti- H. pylori antibodies in 
group A was less than that in group B, however, the 
difference did not reach statistical significance at the 
time of sacrifice. (Table 1) 
Table 1: Summary of the experiment. HP: Inoculation of Helicobacter pylori. mono: mononuclear cells. F/T: the ratio of fundic 
mucosa to total glandular stomach length. *: statistically significant compared with group B (P<0.01). 
    Bacterial 
culture 
 Antibod 
Y titers 
(AI) 
Infiltration 
of 
 Mucosal 
thiskness 
   BrdU 
Labeling 
index 
group HP  Rice 
fluid 
Incidence 
(%) 
Density 
100CFU 
 neutrophils  mono  Antrum 
(mm) 
Corpus 
(mm) 
F/T 
(%) 
 
A (+)  (+)  25*  3.8±2.3 50±60  2.3±0.5* 1.2±0.4* 0.35±0.1  1.2±0.3  43±6  4.0±0.2* 
B (+)  (-)  84  860±990  78±70  2.9±0.3  2.5±0.5 0.39±0.1 1.2±0.1 38±15 6.4±0.7 
C (-)  (+)  -  -  -  0  0  0.19±0.01  0.61±0.1  81±4  0.9±0.2 
D (-)  (-)  -  -  -  0  0  0.20±0.02  0.62±0.1  82±5  0.9±0.1 
 
Histopathological findings  
In animals from non- H. pylori inoculated groups 
(C and D), inflammatory cell infiltration into the lam-
ina propria was negligible (Table 1 and Fig 2C). In 
contrast, active gastritis developed in the gastric mu-
cosa of gerbils in group B (H. pylori inoculation only), 
which thus showed a marked mucosal infiltration of 
inflammatory cells (Table 1 and Fig 2B). In addition, 
superficial erosions in the antrum and irregularity of 
the pyloric glands were frequently observed in group 
B (Fig 2B). However, the degree of mucosal infiltration 
of inflammatory cells (both of neutrophilic polymor-
phonuclear and mononuclear cells) in group A (H. 
pylori inoculation followed by JRF treatment) was sig-
nificantly less than that in group B (Table 1 and Fig 
2A). In addition, no intestinal metaplasia or tumors in 
the gastric mucosa were observed in any groups based 
on the findings of this experiment.   
In addition to serological and bacteriological 
studies, the degree of infection of H. pylori was inves-
tigated by immunostainging. In group B, many H. py-
lori bacteria were detected on the surface of the mu-
cosa (Fig 3B). On the other hand, only a small number 
of bacteria were found to exist in group A (Fig 3A).   
The extent of epithelial proliferation was evalu-
ated based on the BrdU labeling index. The BrdU la-
beling index in group A decreased significantly more 
than that in group B (Table 1), although it increased 
than in the non- H. pylori controls (groups C and D). Int. J. Med. Sci. 2007, 4 
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Figure 2: Histology of pyloric mucosa. H & E, X 40. (A) pyloric mucosa of Mongolian gerbil that was inoculated with H. pylori at 
7 weeks of age and given rice-fluid from 2 weeks until 14 weeks after H. pylori inoculation (group A), (B) pyloric mucosa of 
Mongolian gerbil inoculated with H. pylori and given distilled water (group B), (C) normal (control) pyloric mucosa (group D). The 
degree of mucosal infiltration of inflammatory cells in group A (JRF treatment(+)) (asterisks) was less than that in group B (JRF 
treatment(-))(asterisks). 
 
 
 
Figure 3: Immunostaining for H. pylori, X 80. (A) inoculation with H. pylori with treatment of rice-fluid, (B) inoculation with H. 
pylori without treatment of rice-fluid. Many H. pylori bacteria were detected on the surface of the mucosa in group B (JRF treat-
ment(-)), while only a small number of bacteria were found to exist in group A (JRF treatment(+)). 
 
4.  Discussion 
In the present study, we showed the suppressive 
effect of Japanese rice-fluid (JRF) on H. pylori infection 
in the Mongolian gerbil model. Both cultures and 
immunostaining of the stomach demonstrated a clear 
reduction in the H. pylori colonization. It is natural that 
the difference of anti- H. pylori antibody titers was not 
so large between the JRF -treated gerbils and the 
non-treated ones at the time of sacrifice, since several Int. J. Med. Sci. 2007, 4 
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months are usually needed to show a significant de-
crease in the antibody titers after the eradication of H. 
pylori from the stomach [26]. In addition to the sup-
pressive effect of H. pylori infection, JRF reduced mu-
cosal inflammation and epithelial proliferation in the 
stomach of H. pylori-infected gerbils. It is likely that H. 
pylori-eradication caused a decrease in the degree of 
inflammation in the stomach, although there is a pos-
sibility that JRF itself has an anti-inflammatory effect 
on the gastric mucosa.   
A positive association between a high rice intake 
and atrophic gastritis has been reported in some epi-
demiological studies [27]. However, the direct effect of 
rice on the promotion of atrophic gastritis is still un-
clear. There is a possibility that rice intake is only a 
marker of other dietary factors such as salt or eth-
nic/social factors. Therefore, it is not surprising that a 
substance produced from rice, namely JRF, showed 
both an anti-H.pylori and anti-inflammation effect on 
the stomachs infected with H. pylori. In addition, JRF 
also has completely different activity from rice itself: 
in our in vitro experiment, rice itself did not show any 
anti-H.pylori activity, while JRF showed a strong bac-
tericidal activity against H. pylori [23]. 
Even though the triple therapy, using two anti-
bacterial antibiotics and a proton pump inhibitor, is 
effective and its short duration helps maintain patient 
compliance, a considerable number of patients ex-
perience undesirable side-effects, such as diarrhea, 
epigastric pain, nausea and bloating [28]. Contrary to 
this, JRF is considered to demonstrate relatively few 
side-effects, since rice is eaten as a staple diet in most 
Eastern countries, including Japan. In addition, in the 
in vitro experiment, the antibacterial spectrum of JRF 
was found to be extremely narrow and it was only 
found to be active against some restricted organisms 
including H. pylori, however, it did not demonstrate 
any antibacterial activity against Escherichia coli, Kleb-
siella pneumoniae,  K. oxytoca, or Enterococcus faecalis, 
which are all representative well known normal in-
habitants of the human intestinal flora [23].   
These safety characteristics of JRF may be there-
fore appropriate for the use in prevention of H. pylori 
infection. As chronic inflammation and increased cell 
proliferation are features common to the pathogenesis 
of many human cancers, and as these features seem to 
play a central role in the initiation and promotion of 
carcinogenesis, the suppression of inflammation and 
cell proliferation by JRF may thus be an effective mo-
dality for preventing H. pylori-induced carcinogenesis 
in the stomach.   
In our previous study, a Rice Power Extract 
(RPE) showed a suppressive effect of gastric mucosal 
inflammation, but it did not show significant decrease 
in the viable H. pylori obtained from stomach samples 
[22]. In contrast, JRF showed a significant reduction of 
both H. pylori colonization and mucosal inflammation 
in the stomach. Although both of JRF and RPE are 
made from rice, their constituents could differe 
somewhat between them, since the manufacturing 
method is completely different: JRF is manufactured 
by incubation at high temperatures under high pres-
sure and treatment with proteinase-amylase complex, 
while RPE is prepared by saccharization using Asper-
gillus oryzae and fermentation using Saccharomyces cer-
evisiae  [22]. These manufacturing processes could 
therefore cause the differences observed in the anti-H. 
pylori activity between JRF and RPE. However, the 
mechanism of anti-H. pylori activity in JRF still re-
mains to be elucidated. This mechanism of action 
should be clarified in future studies, and then the 
anti-H. pylori effect should thereafter be confirmed in 
human trials.   
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